Charles River Laboratories International, Inc. (CRL) stock
CRLNYSEServices-Commercial Physical & Biological ResearchFiscal year ends December 27
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 27, 2026Last filing: 10-Q on Nov 4, 2026Score 6/30225% above fair value
$332.16−3.36 (-1.00%)
Close on Nov 17, 2026Market cap $15.86BP/E –Yield –
Charles River Laboratories International operating margin
Operating margin is operating income as a percentage of revenue.
Charles River Laboratories International's operating margin for the twelve months ending Jun 27, 2026 was 2.3%. For fiscal 2025 it was 0.6%, against 5.6% the year before. The highest annual figure on record is 16.7% in fiscal 2021.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | 0.6% | −5.0 |
| FY2024 | Dec 28, 2024 | 5.6% | −9.3 |
| FY2023 | Dec 30, 2023 | 14.9% | −1.4 |
| FY2022 | Dec 31, 2022 | 16.4% | −0.3 |
| FY2021 | Dec 25, 2021 | 16.7% | +1.9 |
| FY2020 | Dec 26, 2020 | 14.8% | +1.4 |
| FY2019 | Dec 28, 2019 | 13.4% | −1.2 |
| FY2018 | Dec 29, 2018 | 14.6% | −0.9 |
| FY2017 | Dec 30, 2017 | 15.5% | +1.4 |
| FY2016 | Dec 31, 2016 | 14.1% | −1.0 |
| FY2015 | Dec 26, 2015 | 15.1% | +1.5 |
| FY2014 | Dec 27, 2014 | 13.7% | +0.7 |
| FY2013 | Dec 28, 2013 | 13.0% | −1.7 |
| FY2012 | Dec 29, 2012 | 14.7% | −0.6 |
| FY2011 | Dec 31, 2011 | 15.3% | +41.6 |
| FY2010 | Dec 25, 2010 | -26.3% | −40.8 |
| FY2009 | Dec 26, 2009 | 14.5% | +49.4 |
| FY2008 | Dec 27, 2008 | -34.9% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 27, 2026 | 11.9% | +2.2 |
| Q1 FY2026 | Mar 28, 2026 | 12.0% | +4.5 |
| Q4 FY2025 | Dec 27, 2025 | -28.5% | −11.8 |
| Q3 FY2025 | Sep 27, 2025 | 13.3% | +1.7 |
| Q2 FY2025 | Jun 28, 2025 | 9.7% | −5.1 |
| Q1 FY2025 | Mar 29, 2025 | 7.6% | −4.9 |
| Q4 FY2024 | Dec 28, 2024 | -16.7% | −29.8 |
| Q3 FY2024 | Sep 28, 2024 | 11.6% | −3.1 |
| Q2 FY2024 | Jun 29, 2024 | 14.8% | −0.8 |
| Q1 FY2024 | Mar 30, 2024 | 12.5% | −3.9 |
| Q4 FY2023 | Dec 30, 2023 | 13.1% | −1.8 |
| Q3 FY2023 | Sep 30, 2023 | 14.8% | −0.5 |
| Q2 FY2023 | Jul 1, 2023 | 15.6% | −3.7 |
| Q1 FY2023 | Apr 1, 2023 | 16.3% | +0.0 |
| Q4 FY2022 | Dec 31, 2022 | 14.9% | −4.2 |
| Q3 FY2022 | Sep 24, 2022 | 15.3% | −2.1 |
| Q2 FY2022 | Jun 25, 2022 | 19.3% | +4.2 |
| Q1 FY2022 | Mar 26, 2022 | 16.3% | +1.3 |
| Q4 FY2021 | Dec 25, 2021 | 19.1% | +2.8 |
| Q3 FY2021 | Sep 25, 2021 | 17.4% | −0.5 |
| Q2 FY2021 | Jun 26, 2021 | 15.0% | +3.8 |
| Q1 FY2021 | Mar 27, 2021 | 15.0% | +1.7 |
| Q4 FY2020 | Dec 26, 2020 | 16.3% | +0.6 |
| Q3 FY2020 | Sep 26, 2020 | 17.9% | +4.0 |
| Q2 FY2020 | Jun 27, 2020 | 11.2% | −0.9 |
| Q1 FY2020 | Mar 28, 2020 | 13.3% | +1.8 |
| Q4 FY2019 | Dec 28, 2019 | 15.7% | −1.3 |
| Q3 FY2019 | Sep 28, 2019 | 13.9% | −0.5 |
| Q2 FY2019 | Jun 29, 2019 | 12.1% | −1.0 |
| Q1 FY2019 | Mar 30, 2019 | 11.5% | −2.2 |
| Q4 FY2018 | Dec 29, 2018 | 17.0% | +3.9 |
| Q3 FY2018 | Sep 29, 2018 | 14.4% | −1.5 |
| Q2 FY2018 | Jun 30, 2018 | 13.1% | −4.3 |
| Q1 FY2018 | Mar 31, 2018 | 13.7% | −1.9 |
| Q4 FY2017 | Dec 30, 2017 | 13.1% | −1.7 |
| Q3 FY2017 | Sep 30, 2017 | 16.0% | +2.1 |
| Q2 FY2017 | Jul 1, 2017 | 17.4% | – |
| Q1 FY2017 | Apr 1, 2017 | 15.6% | – |
| Q4 FY2016 | Dec 31, 2016 | 14.8% | – |
| Q3 FY2016 | Sep 24, 2016 | 13.8% | – |
See a number that looks wrong?